LYEL

20.85

1.12% 0.23

Handel nachbörslich: 20.85

Lyell Immunopharma Inc (LYEL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$20.62

Offen:

$20.67

24-Stunden-Volumen:

36,441

Relative Volume:

0.38

Marktkapitalisierung:

$486.48M

Einnahmen:

$36,000

Nettoeinkommen (Verlust:

$-274.45M

KGV:

-1.7654

EPS:

-11.8105

Netto-Cashflow:

$-150.80M

1W Leistung:

+1.21%

1M Leistung:

-3.87%

6M Leistung:

+16.61%

1J Leistung:

+150.78%

1-Tages-Spanne:

$20.20

$21.27

1-Wochen-Bereich:

$19.59

$21.55

52-Wochen-Spanne:

$7.65

$45.00

Lyell Immunopharma Inc Stock (LYEL) Company Profile

Firmenname

Lyell Immunopharma Inc

Sektor

Healthcare (1111)

Branche

Biotechnology (621)

Telefon

650 695-0677

Adresse

201 HASKINS WAY, SOUTH SAN FRANCISCO

Mitarbeiter

161

Twitter

Nächster Verdiensttermin

2026-05-12

Neueste SEC-Einreichungen

LYEL's Discussions on Twitter

Compare LYEL vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LYEL Lyell Immunopharma Inc	20.85	481.12M	36,000	-274.45M	-150.80M	-11.81
VRTX Vertex Pharmaceuticals Inc	427.65	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	721.05	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	807.55	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	303.00	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	313.32	33.06B	5.36B	287.73M	924.18M	2.5229

Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-10	Eingeleitet	Needham	Buy
2026-03-09	Eingeleitet	Citizens	Mkt Outperform
2025-12-09	Hochstufung	H.C. Wainwright	Neutral → Buy
2024-10-30	Herabstufung	BofA Securities	Buy → Underperform
2024-06-27	Herabstufung	H.C. Wainwright	Buy → Neutral
2023-08-28	Herabstufung	JP Morgan	Overweight → Neutral
2022-11-14	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-11-11	Herabstufung	Goldman	Buy → Neutral
2022-10-17	Eingeleitet	H.C. Wainwright	Buy
2021-07-12	Eingeleitet	BofA Securities	Buy
2021-07-12	Eingeleitet	Goldman	Buy
2021-07-12	Eingeleitet	JP Morgan	Overweight
2021-07-12	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Lyell Immunopharma Inc Aktie (LYEL) Neueste Nachrichten

05:17 AM

Lyell Immunopharma: Q1 Earnings Snapshot - WKYC

05:17 AM

04:29 AM

Lyell starts Phase 3 lymphoma dosing, says cash runway reaches Q3 2027 - Stock Titan

04:29 AM

04:14 AM

Lyell Immunopharma (NASDAQ: LYEL) cuts quarterly loss and raises equity capital - Stock Titan

04:14 AM

04:10 AM

Lyell Immunopharma (NASDAQ: LYEL) trims Q1 loss and advances CAR T trials - Stock Titan

04:10 AM

May 04, 2026

Lyell Immunopharma (LYEL) Price Target Increased by 27.27% to 14.28 - MSN

May 04, 2026

May 03, 2026

LYEL SEC FilingsLyell Immunopharma, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

May 03, 2026

May 02, 2026

BofA Securities Maintains Lyell Immunopharma(LYEL.US) With Sell Rating, Maintains Target Price $12 - Moomoo

May 02, 2026

Lyell Immunopharma (NASDAQ:LYEL) Upgraded by Robert W. Baird to Strong-Buy Rating - MarketBeat

May 02, 2026

Lyell Immunopharma (NASDAQ:LYEL) Downgraded to Sell Rating by Wall Street Zen - MarketBeat

May 02, 2026

May 01, 2026

Baird initiates Lyell Immunopharma stock with outperform rating By Investing.com - Investing.com South Africa

May 01, 2026

Baird initiates Lyell Immunopharma stock with outperform rating - Investing.com

May 01, 2026

BofA reiterates Lyell Immunopharma stock Underperform on rival exit - Investing.com

May 01, 2026

BofA reiterates Lyell Immunopharma stock Underperform on rival exit By Investing.com - Investing.com India

May 01, 2026

Apr 29, 2026

Lyell Immunopharma climbs after reporting strong CAR T-cell therapy results - MSN

Apr 29, 2026

Apr 24, 2026

[ARS] Lyell Immunopharma, Inc. SEC Filing - Stock Titan

Apr 24, 2026

Lyell Immunopharma (NASDAQ: LYEL) outlines 2026 virtual meeting, board elections and pay vote - Stock Titan

Apr 24, 2026

Lyell Immunopharma (NASDAQ:LYEL) Shares Gap DownHere's What Happened - MarketBeat

Apr 24, 2026

Apr 23, 2026

LYEL (Lyell Immunopharma Inc.) reports far wider than expected Q4 2025 loss as shares tick modestly higher.Pro Level Trade Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026

Apr 21, 2026

Euler Fund (NASDAQ: LYEL) holds 1,426,528 shares, 6.71% stake disclosed - Stock Titan

Apr 21, 2026

Apr 20, 2026

Lyell Immunopharma (LYEL) Stock: Gaining Traction? (Underperforming) 2026-04-20Retail Money Flow - Xã Thanh Hà

Apr 20, 2026

Apr 18, 2026

Lyell Immunopharma (NASDAQ:LYEL) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat

Apr 18, 2026

Apr 17, 2026

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Large Increase in Short Interest - MarketBeat

Apr 17, 2026

LYEL Earnings History & Surprises | EPS & Revenue Results | LYELL IMMUNOPHARMA INC (NASDAQ:LYEL) - ChartMill

Apr 17, 2026

Apr 16, 2026

A First Look At Lyell Immunopharma (NASDAQ:LYEL) - Seeking Alpha

Apr 16, 2026

Apr 15, 2026

[EFFECT] Lyell Immunopharma, Inc. SEC Filing - Stock Titan

Apr 15, 2026

Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel - The Manila Times

Apr 15, 2026

Apr 14, 2026

Lyell Immunopharma (NASDAQ:LYEL) Shares Down 4%Should You Sell? - MarketBeat

Apr 14, 2026

Apr 13, 2026

Lyell Immunopharma (NASDAQ:LYEL) Stock Price Up 6.9%Should You Buy? - MarketBeat

Apr 13, 2026

Apr 11, 2026

This WhiteFiber Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Sahm

Apr 11, 2026

Needham initiates coverage of Lyell Immunopharma (LYEL) with buy recommendation - MSN

Apr 11, 2026

Apr 10, 2026

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

Apr 10, 2026

Needham & Company LLC Begins Coverage on Lyell Immunopharma (NASDAQ:LYEL) - MarketBeat

Apr 10, 2026

Is Lyell Immunopharma (LYEL) Stock Attractive Now | Price at $23.72, Down 0.55%Pro Trader Recommendations - Newser

Apr 10, 2026

Lyell Immunopharma (NASDAQ:LYEL) Cut to Strong Sell at Zacks Research - Defense World

Apr 10, 2026

Apr 08, 2026

Signal Recap: Will Lyell Immunopharma Inc outperform tech stocksQuarterly Performance Summary & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn

Apr 08, 2026

Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference - Sahm

Apr 08, 2026

Apr 07, 2026

Lyell Immunopharma to Present at 25th Annual Needham Virtual Healthcare Conference - National Today

Apr 07, 2026

Cancer drug developer Lyell will webcast a management presentation Apr. 14 - Stock Titan

Apr 07, 2026

Apr 06, 2026

Head to Head Analysis: Lyell Immunopharma (NASDAQ:LYEL) & Mangoceuticals (NASDAQ:MGRX) - Defense World

Apr 06, 2026

Apr 03, 2026

Lyell Immunopharma registers 1.95M shares for resale (NASDAQ: LYEL) - Stock Titan

Apr 03, 2026

Apr 01, 2026

Lyell Immunopharma (NASDAQ:LYEL) Trading Up 9.2%Time to Buy? - MarketBeat

Apr 01, 2026

US Stocks Recap: How sensitive is Lyell Immunopharma Inc to inflation2026 Risk Factors & Reliable Entry Point Alerts - baoquankhu1.vn

Apr 01, 2026

Mar 28, 2026

Lyell Immunopharma (NASDAQ:LYEL) Lowered to Sell Rating by Wall Street Zen - MarketBeat

Mar 28, 2026

Mar 23, 2026

LYEL Technical Analysis & Stock Price Forecast - Intellectia AI

Mar 23, 2026

Lyell Immunopharma: Strong Early CAR-T Data, And Now A More Measured Bet (NASDAQ:LYEL) - Seeking Alpha

Mar 23, 2026

H.C. Wainwright reiterates Lyell Immunopharma stock rating at buy By Investing.com - Investing.com Canada

Mar 23, 2026

Mar 17, 2026

Is Lyell Immunopharma Inc impacted by rising rates2026 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn

Mar 17, 2026

Mar 16, 2026

Lyell Immunopharma (LYEL) grants CFO 140,000 stock options - Stock Titan

Mar 16, 2026

Lyell Immunopharma (LYEL) CFO Shah identified as insider in Form 3 - Stock Titan

Mar 16, 2026